News tagged with cardiovascular drugs
FDA recommends lower doses of anemia drugs
(AP) -- Food and Drug Administration officials say doctors should use lower doses of anemia drugs when treating patients with failing kidneys due to the increased risk of stroke, blood clots and death.
Medicine & Health / Medications
Jun 24, 2011 |
not rated yet |
0
Pfizer anti-smoking drug has heart risks: US
US regulators said Thursday that the label on Pfizer's anti-smoking drug Chantix must be changed to warn of a slightly higher risk of heart problems in patients who already have cardiovascular disease.
Medicine & Health / Medications
Jun 16, 2011 |
not rated yet |
0
FDA adds heart warning to Pfizer anti-smoking pill
(AP) -- Federal health regulators are warning doctors and patients that Pfizer's anti-smoking drug Chantix may slightly increase the risk of heart attack and other cardiovascular problems.
Medicine & Health / Medications
Jun 16, 2011 |
not rated yet |
0
Drug reduces gum disease, risk of osteoporosis, heart disease in women
(PhysOrg.com) -- New research has shown that a federally approved pharmaceutical for treating periodontal disease also significantly reduces risk of osteoporosis and cardiovascular disease in postmenopausal ...
Medicine & Health / Medications
Mar 10, 2011 |
5 / 5 (2) |
0
New hypothesis explains why drugs increase risk of heart attacks and strokes
New research shows that medications which have raised safety concerns over heart attack and stroke risks may not have gotten approval from the Food and Drug Administration (FDA) if the cardiovascular effects of fluid retention ...
Medicine & Health / Medications
Feb 23, 2011 |
5 / 5 (1) |
0
FDA rejects highly-anticipated diet drug Qnexa
(AP) -- Federal health regulators have decided not to approve an experimental diet pill called Qnexa, which had been touted by many experts as the most promising weight-loss drug in more than a decade.
Medicine & Health / Medications
Oct 29, 2010 |
4.5 / 5 (2) |
0
People at 'intermediate risk' of heart disease with elevated hsCRP benefit from statin therapy
Women and men with a 10-year cardiovascular disease risk of 5 percent or more and normal cholesterol levels but high levels of hsCRP, a protein associated with inflammation, could reduce their risk substantially with statin ...
Medicine & Health / Diseases, Conditions, Syndromes
Aug 24, 2010 |
4 / 5 (1) |
1
Decade-long trial confirms benefts of steroid withdrawal for transplant patients
A University of Cincinnati (UC) analysis of 10 years of data from local kidney transplant patients shows that patients removed from a corticosteroid regimen shortly after surgery have better graft survival rates, better survival ...
Aug 23, 2010 |
not rated yet |
0
FDA issues hold on much-debated Avandia study
(AP) -- Federal health officials are barring new patients from enrolling in a safety study of GlaxoSmithKline's controversial diabetes pill Avandia, a week after a panel of experts ruled that the drug increases ...
Medicine & Health / Medications
Jul 21, 2010 |
not rated yet |
0
Arizona man is first to go home with a total artificial heart
(PhysOrg.com) -- An Arizona man has left hospital with a completely artificial heart beating in his chest. Father of three Charles Okeke, 43, from Phoenix is the first person to leave hospital with a Total ...
Medicine & Health / Medical research
May 28, 2010 |
4.7 / 5 (26) |
7
|
Monitoring and control can limit side effects of promising cancer drugs
A new class of cancer drugs can be used effectively while minimizing hypertensive side effects if patients' blood pressure is closely monitored and controlled, a clinical panel has determined.
May 11, 2010 |
not rated yet |
0
UH engineers to improve test for cardiovascular disease
Two University of Houston professors are working to help keep your heart beating stronger and longer simply by monitoring the temperature of your fingertip.
Medicine & Health / Medical research
May 05, 2010 |
not rated yet |
0
New publication focuses on molecular imaging and cardiovascular conditions
The Journal of Nuclear Medicine (JNM)—the top-rated medical imaging journal worldwide—has published Multimodality Molecular Imaging of the Cardiovascular System, presenting the state of the art of cardiovascular molecular imagin ...
Medicine & Health / Medical research
May 03, 2010 |
not rated yet |
0
Patient's whole genome reveals risk of diseases and adverse drug responses
Scientists at Stanford and Harvard Universities collaborated to assess the clinical usefulness of analyzing a patient's full genome for disease risks and unusual drug responses. The work brings closer to reality the concept ...
Apr 29, 2010 |
4.3 / 5 (6) |
0
|
Gene test shows who could benefit from statins to reduce colon cancer risk
A genetic test can help determine in which patients cholesterol-lowering statin drugs might have the most benefit in also reducing the risk of colorectal cancer, a new study from researchers at the University of Michigan ...
Apr 19, 2010 |
not rated yet |
0
|
